DIA INDIA 7th Annual Conference - November 1-4 Hyderabad

Listen to Paul Huckle & Adrian McKemey - Keynote Speakers at 7th Annual Conference KEYNOTE SPEAKER 1 Paul Huckle Senior Vice President Global Regulatory Affairs GlaxoSmithKline   KEYNOTE SPEAKER 2 Adrian McKemey Practice Leader, Product Development & Commercialization Quintiles The 7th Annual Conference this year will begin with Keynote Addresses from Paul Huckle, Senior Vice President, Global Regulatory Affairs, GlaxoSmithKline and Adrian McKemey, Practice Leader, Product Development & Commercialization, Quintiles. The three day conference through 25 sessions and 3 tutorials on the theme 'Innovative Strategies for Individualized Health Care' will bring together regulators and pharma professionals working in the discovery, development, manufacturing or commercialization fields, academicians working in the fields related to the healthcare industry, finance professionals working in the healthcare sector and patient advocacy groups. To know more on the conference program here are a few session details.   Scientific, Regulatory and Ethical Challenges in Advancing Personalized Medicine  This session chaired by Carol Isaacson Barash, Principal, Helix Health Advisors, Adjunct Prof. Personalized Medicine, Regis College will discuss Realizing the Promise of Personalization through Healthcare Mass Commercialization by Sagar Kamarthi, Associate Professor, Department of Mechanical and Industrial Engineering, Northeastern University, Boston Regulatory Challenges for Molecular and Companion Diagnostics by Jeffrey N. Gibbs, Director Hyman, Phelps & McNamara, P. C. Ethical Issues in Individualized Health Care — Seeking Solutions in a Complex World by Aamir Shaikh, Founder Assansa Personalized Nutrition: Parallels from Personalized Medicine by Emanuelle Voisin, CEO and Principal, Voisin Consulting   Register Online      Read More Therapeutics — Pharmacology and Applications in Personalise Medicine This session chaired by Vishwas Sovani, Country Manager, Revogenex, Inc. will discuss Personalised Medicine Pharmacological basis by Vishwas Sovani, Country Manager, Revogenex, Inc. Therapeutic Applications of Personalized Medicine by Mangesh Kulkarni, Group Head, DS&E Novartis Healthcare Ready to use Kits for Personalized Medicine by Mukesh Agrawal, Vice President - CRL, Vimta Labs   Register Online      Read More Personalized Precision Medicine: Regulatory, Financial and Ethical Challenges to Ensuring its Growth  This panel chaired by Carol Isaacson Barash, Principal, Helix Health Advisors, Adjunct Prof. Personalized Medicine, Regis College will consist of the following panelists Jeffrey N. Gibbs, Director, Hyman, Phelps & McNamara, P. C. Arun Mishra, Director, Global Regulatory Affairs, Asia-Pacific, Japan, Emerging Markets, GlaxoSmithKline Shoibal Mukherjee, Vice President and Head, Asia Medical Sciences Group, Quintiles Nandini K. Kumar, Former Deputy Director General, Sr. Grade Investigator NIH project, National Institute of Epidemiology Femida Gwadry-Sridhar, Director, Health Informatics, Lawson Health Research Institute Sagar Kamarthi, Associate Professor, Department of Mechanical and Industrial Engineering Northeastern University, Boston   Register Online     Read More 7th Annual Conference Registration Fees Reduced Registration fees at the 7th Annual Conference have been reduced by nearly 20% to as low as Rs. 9,000 + taxes to help the industry participate in large numbers and gain immensely through this unique networking opportunity. Click here to view the conference program with over 75 International & India industry leaders. For more information and group registrations please contact Rhean.DSouza@diaindia.org or call +91.98.2058.7798. Follow us and tweet on the 7th Annual Conference with #DIAIndiaAM2012   Register Online      Read More Thank You to our 7th Annual Conference Supporters Level 2 Level 1 Email Preferences    |    My DIA    |    Forward to a Friend    |

Innovative Strategies for Individualized Health Care - November 1-4 Hyderabad

. Innovative Strategies for Individualized Health Care KEYNOTE SPEAKER Paul Huckle Senior Vice President Global Regulatory Affairs GlaxoSmithKline DIA India’s 7th Annual Conference: "Discovery Through Commercialization - Innovative Strategies for Individualized Health Care" is your only chance this year to interact and network with the largest gathering of International and Indian Regulators and Pharma professionals in India. This year at Hyderabad International Convention Centre (HICC), Hyderabad, this conference and exhibition will bring together over 400 of your key past, present and future patrons. There are over 100 international and Indian industry leaders who will present and discuss pertinent and relevant issues in 25 key sessions on topics related to Drug Discovery, Development, Manufacturing, Commercialization, Regulatory, Ethical, Social, Legal, Technology & Standards, Lean Strategy, Outsourcing Strategy, Pharmacovigilance and Therapeutics. For more information please click here to view the conference brochure or contact Rhean.DSouza@diaindia.org or call +91.98.2058.7798.  Read More Participant Profile of Last Year's Conference Attendees - - - - - - - - - - - - - - - - - Program Highlights Discovery: Bioinformatics, Next Gen Sequencing, Lead optimization – the need for speed Development: Barriers and drivers relevant to clinical development across clinical operations, data management, biostatistics, programming, and medical writing, highlighting systems biology paradigm (e.g. pharmacogenomics, metabolomics) and innovative developmental approaches (e.g. chronotherapeutics, microdosing) Manufacturing: Flexible solutions to adapt to the evolving global regulatory scenario and quality standards Commercialization: Health economics and outcomes research driving product and pricing strategy, patient access, payor challenges, Go-to-investors and financial/partnering strategies for product development Regulatory, ethical, social and legal issues: Data privacy and consent issues in the evolving technologies related to personalized medicine Technology and Standards: Technology – SOA, the Cloud and the future, Data and Semantic Interoperability Technology, GRC (Governance, Regulation and Compliance) all focused on Personalized Medicine.  Lean strategy: The application of Lean in pharmacovigilance, medical writing, clinical operations and site performance. Driving the critical path. The conference will address the strategy for drug discovery and clinical development pipeline and faster time to market in the era of blockbuster patient expiries and issues of integrating and streamlining data flows across the entire life cycle of the molecule, and the standardization and rigor that needs to be implemented. It will also stress upon the ethical, legal, social and regulatory and financial and investments challenges impacting all of the above and how processes and technology will need to be upgraded to support the same. To know more contact Rhean.DSouza@diaindia.org or call +91.98.2058.7798.  Read More Exhibit Details With over 9500 square feet of area the exhibition this year hosted at Hyderabad International Convention Centre (HICC), will help you connect with over 400 patrons. As an exhibitor you will be entitled to: Two complimentary conference passes Two complimentary exhibit booth attendee passes Pre-fitted shell scheme booth structure Fascia board with 25 character company name One electrical connection Three spotlights One table Two chairs One wastebasket Carpet Exhibit Fee: 3m x 2m booth space - INR 168,540/- (inclusive of taxes) Please click here to view the Exhibit Layout and Booking Form. For more details contact Manoj.Trivedi@diaindia.org  or call +91.98.1977.7493.  Read More Email Preferences    |    My DIA    |    Forward to a Friend    |